A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.
Launched by GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD. · May 15, 2024
Trial Information
Current as of May 19, 2025
Withdrawn
Keywords
ClinConnect Summary
This randomized study will compare the cumulative procedure time between cystoscopy performed with the Redpine® Rflex endo(trademark) High-Definition Cystoscope and the site's standard of care reusable flexible cystoscope in adult study participants requiring cystoscopy for visualization of and/or intervention on the urinary bladder. The study will evaluate the user experience and product performance during cystoscopic procedures. Participant experience, tolerance to the procedure, and any differences in adverse events between disposable and reusable scope will be evaluated. The hypothesis ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female, aged at least 18 years old
- • 2. Patient undergoing routine flexible cystoscopy
- • 3. No active urinary tract infection
- • 4. Subject is willing and able to sign informed consent and HIPAA authorization.
- Exclusion Criteria:
- • 1. Known unpassable urethral stricture
- • 2. Febrile patient with active urinary tract infection (UTI)
- • 3. Subjects with acute infection (acute urethritis, acute prostatitis, acute epididymitis)
- • 4. Subject with severe coagulopathy
- • 5. Subject is pregnant or female with reproductive capability who is unwilling to have a pre-procedure pregnancy test and use birth control.
About Guangzhou Red Pine Medical Instrument Co., Ltd.
Guangzhou Red Pine Medical Instrument Co., Ltd. is a leading medical device manufacturer specializing in the development and production of innovative healthcare solutions. With a commitment to enhancing patient outcomes and advancing medical technologies, the company focuses on high-quality instrumentation for various clinical applications. Leveraging state-of-the-art manufacturing processes and rigorous quality control measures, Guangzhou Red Pine aims to meet international standards and regulatory requirements. Through strategic partnerships and a dedication to research and development, the company actively contributes to the global healthcare landscape, fostering advancements that improve diagnostic accuracy and treatment efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Dallas, Texas, United States
Hershey, Pennsylvania, United States
Hersey, Pennsylvania, United States
Patients applied
Trial Officials
Yair Lotan, MD
Principal Investigator
UT Southwestern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported